Global Reversible Contraceptive Devices Market

Global Reversible Contraceptive Devices Market Size Insights Forecasts to 2035

• The Global Reversible Contraceptive Devices Market Size Was valued at USD 1.6 Billion in 2024
• The Global Reversible Contraceptive Devices Market Size is Expected to Grow at a CAGR of around 10.08% from 2025 to 2035
• The Worldwide Reversible Contraceptive Devices Market Size is Expected to Reach USD 4.6 Billion by 2035
• Asia-Pacific is expected to grow the fastest during the forecast period.

According to a research report published by Decisions Advisors and Consulting, The Global Reversible Contraceptive Devices Market Size Was Worth Around USD 1.6 Billion In 2024 And Is Predicted To Grow To Around USD 4.6 Billion By 2035 With A Compound Annual Growth Rate (CAGR) Of 10.08% From 2025 To 2035. The worldwide reversible contraceptive device market continues to expand because of increasing awareness about family planning combined with rising interest in permanent reversible contraceptive methods and technological advancements and government programs that support the field and improving accessibility throughout developing markets.

 

Market Overview

The Global Reversible Contraceptive Devices Market Size refers to medical devices designed to prevent pregnancy while allowing users to restore fertility after discontinuation. The devices which make up this category include intrauterine devices (IUDs) as well as contraceptive implants and vaginal rings and injectable contraceptives. The market experiences growth because people increasingly understand family planning while more individuals choose long-acting reversible contraceptives and society puts greater importance on women's reproductive health. The market expansion receives additional support from technological advancements which enhance safety and comfort and operational efficiency. Government programs and non-profit initiatives together with developing regions' enhanced healthcare systems, create better access to products. The increasing adoption of products results from changing lifestyles which include postponing pregnancies and increased healthcare spending. The market will experience growth restrictions because of side effects and cultural obstacles and limited public knowledge which exist in specific areas throughout the projected timeframe.

 

Report Coverage

This research report categorizes the reversible contraceptive devices market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the reversible contraceptive devices market. Recent market developments and competitive strategies such as expansion, type launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the reversible contraceptive devices market. 

 

Driving Factors

The reversible contraceptive device market experiences growth because people now understand and accept family planning methods. The World Health Organization published a report which shows that developing regions still experience unmet family planning needs, although educational programs have improved contraceptive access. Users find long-acting reversible contraceptives (LARCs) more attractive because product design and functionality innovations have created new design elements. IUDs offer effectiveness rates above 99%, which makes them the most popular option among women. The development of this technology improves user experience while creating trustworthiness for reversible contraceptive methods.

 

Restraining Factors

The continuous flow of false information about contraceptive methods makes it difficult to expand the market. The public's understanding of reversible contraceptive methods depends on their perception of past social stigmas and existing false beliefs. The stakeholders need to focus their efforts on educational programs and awareness campaigns which will help people understand contraceptive methods and make better choices.

 

Market Segmentation

The reversible contraceptive devices market share is classified into device type and material.

 

• The intrauterine devices (IUDs) segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period.           

Based on the device type, the reversible contraceptive devices market is divided into intrauterine devices (IUDs), hormonal contraceptive devices. Among these, the intrauterine devices (IUDs) segment accounted for the largest share in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The segment demonstrates its attributes through its high effectiveness which provides long-term protection and operates at a cost-effective level while requiring almost no maintenance. The market displays strong growth because people now understand long-acting reversible contraceptives more than before and they choose non-surgical methods instead of surgical ones and the existing reimbursement policies benefit them and public healthcare programs provide wider access to these contraceptives.     

   

• The plastic devices segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period.     

Based on the material, the reversible contraceptive devices market is divided into plastic devices and metal devices. Among these, the plastic devices segment accounted for the highest market revenue in 2024 and is anticipated to grow at a significant CAGR during the forecast period. The superior biocompatibility of segment leads together with their decreased side effect risk and improved user comfort results in better performance than metal devices. The product gains market acceptance through its lightweight design and flexible features which enable users to use hormonal treatments. The market experiences strong growth because of three factors which include ongoing material innovations and decreasing production expenses and the increasing demand for safer contraceptive options which are easy for patients to use.    

 

Regional Segment Analysis of the Reversible Contraceptive Devices Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

 

North America is anticipated to hold the largest share of the reversible contraceptive devices market over the predicted timeframe.

North America is anticipated to hold the largest share of the reversible contraceptive devices market over the predicted timeframe. The combination of widespread knowledge about reproductive health and the common use of long-acting reversible contraceptives and the existence of strong healthcare systems all drive this situation. The region experiences increased product adoption because of its favorable reimbursement policies and presence of major manufacturers and supportive government programs and accessible advanced medical technologies.

 

Asia-Pacific is expected to grow at a rapid CAGR in the reversible contraceptive devices market during the forecast period. The population growth in reproductive age women combined with rising family planning awareness and the expansion of government programs that promote contraceptive use. The combination of better healthcare facilities and more affordable medical equipment and the increase of urban areas and international health organization support has enabled emerging economies in the region to rapidly adopt new technologies.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the reversible contraceptive devices market, along with a comparative evaluation primarily based on their type of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes type development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

• Allergan Aesthetics
• Bayer AG
• CooperSurgical Inc
• Organon
• Meril Life Sciences Pvt Ltd
• Pregna International Ltd
• Shanghai Dahua Pharmaceuticals Co Ltd
• HLL Lifecare Ltd
• Kessel Medintim GmbH
• Others

 

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

 

Recent Development

 

• In July 2025, The WHO reported that among 1.9 billion women of reproductive age, 1.1 Billion needed family planning and 874 Million used modern contraception. Access supported health, human rights, and reduced unintended pregnancies, though 164 million still had unmet needs. Condoms uniquely prevented both pregnancy and STIs.

 

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Decisions Advisors has segmented the reversible contraceptive devices market based on the below-mentioned segments: 

 

Global Reversible Contraceptive Devices Market, By Device Type

• Intrauterine Devices (IUDs)
• Hormonal Contraceptive Devices

 

Global Reversible Contraceptive Devices Market, By Material

• Plastic Devices
• Metal Devices

 

Global Reversible Contraceptive Devices Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  •  South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa

 

Frequently Asked Questions (FAQ)

1. What is the CAGR of the reversible contraceptive devices market over the forecast period?

A: The global reversible contraceptive devices market is projected to expand at a CAGR of 10.08% during the forecast period.

 

2. What is the market size of the reversible contraceptive devices market?

A: the global reversible contraceptive devices market size is estimated to grow from USD 1.6 Billion in 2024 to USD 4.6 Billion by 2035, at a CAGR of 10.08% during the forecast period 2025-2035.  

 

3. Which region holds the largest share of the reversible contraceptive devices market?

A: North America is anticipated to hold the largest share of the reversible contraceptive devices market over the predicted timeframe.

 

4. Who are the top 10 companies operating in the global reversible contraceptive devices market?

A: Allergan Aesthetics, Bayer AG, CooperSurgical Inc, Organon, Meril Life Sciences Pvt Ltd, Pregna International Ltd, Shanghai Dahua Pharmaceuticals Co Ltd, HLL Lifecare Ltd, Kessel Medintim GmbH, and Others.

 

5. What are the market trends in the reversible contraceptive devices market?

A: The reversible contraceptive devices market shows key trends through the rising use of long-acting reversible contraceptives together with technological improvements which enhance device safety and comfort and through the increased public knowledge of reproductive health and the higher financial and operational support from governments and NGOs worldwide.